title: Commentary: Triple therapy for patients with chronic hepatitis C and advanced fibrosis? Authors' reply.
authors.affiliation: Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan. eogawa@gim.med.kyushu-u.ac.jp.
authors.forename: E
authors.initials: E
authors.lastname: Ogawa
authors.forename: N
authors.initials: N
authors.lastname: Furusyo
authors.forename: J
authors.initials: J
authors.lastname: Hayashi
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D009842:Oligopeptides; C486464:telaprevir